Spatio-Temporal Expression Pattern of Ki-67, PRB, MMP-9 and Bax in Human Secondary Palate Development
Overview
Authors
Affiliations
We analyzed the immunohistochemical expression of Ki-67, pRb, Bax, and MMP-9 during the human secondary palate formation (7th to 12th developmental weeks (DWs). The most significant proliferation was observed in the seventh DW with 32% of Ki-67-positive cells in the epithelium, while loose ectomesenchyme condensations (lec) and loose non-condensing ectomesenchyme (lnc) had only 18 and 11%, respectively (Kruskal-Wallis, < 0.001), and diminished afterwards. Contrarily, pRb-positive cells were mostly located in the lnc (67%), with significant difference in comparison to epithelium and lec in all investigated periods (Kruskal-Wallis, < 0.001). Ki-67- and pRb-positive cells co-expressed occasionally in all investigated periods. MMP-9 displayed a strong expression pattern with the highest number of positive cells during the seventh DW in the epithelium, with significant difference in comparison to lec and lnc (Kruskal-Wallis, < 0.0001). The ninth DW is particularly important for the Bax expression, especially in the epithelium (84%), in comparison to lec (58%) and lnc (47%) (Kruskal-Wallis, < 0.001). The co-expression of Bax and MMP-9 was seen only in the epithelium during seventh and ninth DWs. Our study indicates the parallel persistence of proliferation (Ki-67, pRb) and remodeling (MMP-9) that enables growth and apoptotic activity (Bax) that enable the removal of the epithelial cells at the fusion point during secondary palate formation.
8-Br-cGMP suppresses tumor progression through EGFR/PLC γ1 pathway in epithelial ovarian cancer.
Wu M, Mu C, Yang H, Wang Y, Ma P, Li S Mol Biol Rep. 2024; 51(1):140.
PMID: 38236447 DOI: 10.1007/s11033-023-09037-5.
An improved multicellular human organoid model for the study of chemical effects on palatal fusion.
Wolf C, Fitzpatrick H, Becker C, Smith J, Wood C Birth Defects Res. 2023; 115(16):1513-1533.
PMID: 37530699 PMC: 11253831. DOI: 10.1002/bdr2.2229.
Buile D, Pilmane M, Akota I Pediatr Rep. 2022; 14(4):419-433.
PMID: 36278554 PMC: 9590111. DOI: 10.3390/pediatric14040050.